Ident. | Authors (with country if any) | Title |
---|
000002 (2020) |
Jing Xu [République populaire de Chine] ; Han Zhang [République populaire de Chine] ; Jinfang Zheng [États-Unis] ; Philippe Dovoedo [États-Unis] ; Yanbin Yin [États-Unis] | eCAMI: simultaneous classification and motif identification for enzyme annotation. |
000007 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
000008 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
000010 (2020) |
Peter Kranke ; Stephanie Weibel ; Magdalena Sitter ; Patrick Meybohm ; Thierry Girard | [Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees]. |
000028 (2020) |
Jennifer Cable [États-Unis] ; Padmini Srikantiah [États-Unis] ; James E. Crowe [États-Unis] ; Bali Pulendran [États-Unis] ; Adrian Hill [Royaume-Uni] ; Ann Ginsberg [États-Unis] ; Wayne Koff [États-Unis] ; Anuja Mathew [États-Unis] ; Tony Ng [États-Unis] ; Kathrin Jansen [États-Unis] ; Gregory Glenn [États-Unis] ; Sallie Permar [États-Unis] ; Ian Wilson [États-Unis] ; David B. Weiner [États-Unis] ; Drew Weissman [États-Unis] ; Rino Rappuoli [Royaume-Uni] | Vaccine innovations for emerging infectious diseases-a symposium report. |
000033 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
000034 (2020) |
Vineet D. Menachery [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Andrew Hale [États-Unis] ; Rachel L. Graham [États-Unis] ; Trevor Scobey [États-Unis] ; Simon J. Anthony [États-Unis] ; Lingshu Wang [États-Unis] ; Barney Graham [États-Unis] ; Scott H. Randell [États-Unis] ; W Ian Lipkin [États-Unis] ; Ralph S. Baric [États-Unis] | Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection. |
000043 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
000050 (2020) |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
000051 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus |
000052 (2020) |
S Nia Garcia [Espagne] ; Jonathan F. Wendel [États-Unis] ; Natalia Borowska-Zuchowska [Pologne] ; Malika Aïnouche [France] ; Alena Kuderova ; Ales Kovarik | The Utility of Graph Clustering of 5S Ribosomal DNA Homoeologs in Plant Allopolyploids, Homoploid Hybrids, and Cryptic Introgressants |
000059 (2020) |
| The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective |
000061 (2020) |
Sang-Hwa Oh ; Seo Yoon Lee ; Changhyun Han | The Effects of Social Media Use on Preventive Behaviors during Infectious Disease Outbreaks: The Mediating Role of Self-relevant Emotions and Public Risk Perception. |
000062 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
000066 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
000071 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
000073 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
000077 (2020) |
Isabel Ortiz De Solorzano [Espagne] ; Karteek K. Bejagam ; Yaxin An ; Samrendra K. Singh ; Sanket A. Deshmukh | Solvation dynamics of N-substituted acrylamide polymers and the importance for phase transition behavior. |
000082 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
000090 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |
000095 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
000107 (2020) |
Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. |
000110 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
000111 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
000112 (2020) |
A Jin Cho [Corée du Sud] ; Hong-Seock Lee [Corée du Sud] ; Young-Ki Lee [Corée du Sud] ; Hee Jung Jeon [Corée du Sud] ; Hayne Cho Park [Corée du Sud] ; Da-Wun Jeong [Corée du Sud] ; Yang-Gyun Kim [Corée du Sud] ; Sang-Ho Lee [Corée du Sud] ; Chang-Hee Lee [Corée du Sud] ; Kyung Don Yoo [Corée du Sud] ; Ae Kyeong Wong [Corée du Sud] | Post-traumatic stress symptoms in hemodialysis patients with MERS-CoV exposure |
000115 (2020) |
Frederick M. Burkle | Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us. |
000122 (2020) |
James Lyons-Weiler | Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |
000129 (2020) |
Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis] | Novel ionophores active against La Crosse virus identified through rapid antiviral screening. |
000139 (2020) |
Beomju Hwang [Japon] ; Hirohiko Ise [Japon] | Multimeric conformation of type III intermediate filaments but not the filamentous conformation exhibits high affinity to lipid bilayers. |
000142 (2020) |
Yuan Yuan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Ruchao Peng [République populaire de Chine] ; Chunrui Li [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Qihui Wang [République populaire de Chine] ; George Fu Gao [République populaire de Chine] | Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species. |
000150 (2020) |
Jaffar A. Al-Tawfiq [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] | Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus. |
000152 (2020) |
Susanna K. P. Lau [Hong Kong] ; Kenneth S. M. Li [Hong Kong] ; Hayes K. H. Luk [Hong Kong] ; Zirong He [Hong Kong] ; Jade L. L. Teng [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; Ulrich Wernery [Émirats arabes unis] ; Patrick C. Y. Woo [Hong Kong] | Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai |
000155 (2020) |
Eun Kim [États-Unis] ; Geza Erdos [États-Unis] ; Shaohua Huang [États-Unis] ; Thomas W. Kenniston [États-Unis] ; Stephen C. Balmert [États-Unis] ; Cara Donahue Carey [États-Unis] ; V. Stalin Raj [Pays-Bas] ; Michael W. Epperly [États-Unis] ; William B. Klimstra [États-Unis] ; Bart L. Haagmans [Pays-Bas] ; Emrullah Korkmaz [États-Unis] ; Louis D. Falo [États-Unis] ; Andrea Gambotto [États-Unis] | Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development |
000171 (2020) |
| Influenza, Measles, SARS, MERS, and Smallpox |
000184 (2020) |
Neetha Nanoth Vellichirammal [États-Unis] ; Abrar Albahrani [États-Unis] ; You Li [République populaire de Chine] ; Chittibabu Guda [États-Unis] | Identification of Fusion Transcripts from Unaligned RNA-Seq Reads Using ChimeRScope. |
000185 (2020) |
Jeong-Min Kim [Corée du Sud] ; Yoon-Seok Chung [Corée du Sud] ; Hye Jun Jo [Corée du Sud] ; Nam-Joo Lee [Corée du Sud] ; Mi Seon Kim [Corée du Sud] ; Sang Hee Woo [Corée du Sud] ; Sehee Park [Corée du Sud] ; Jee Woong Kim [Corée du Sud] ; Heui Man Kim [Corée du Sud] ; Myung-Guk Han [Corée du Sud] | Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 |
000190 (2020) |
Leila Mousavizadeh [Allemagne] ; Sorayya Ghasemi [Iran] | Genotype and phenotype of COVID-19: Their roles in pathogenesis |
000200 (2020) |
Xuhua Xia [Canada] | Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. |
000215 (2020) |
Franck Katembo Sikakulya ; Olivier Mulisya ; Dalton Kambale Munyambalu [Ouganda] ; Gabriel Kambale Bunduki | Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control. |
000220 (2020) |
Enya Qing [États-Unis] ; Michael Hantak [États-Unis] ; Stanley Perlman [États-Unis] ; Tom Gallagher [États-Unis] | Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection |
000225 (2020) |
Manojit Bhattacharya [Corée du Sud] ; Ashish R. Sharma [Corée du Sud] ; Prasanta Patra [Inde] ; Pratik Ghosh [Inde] ; Garima Sharma [Corée du Sud] ; Bidhan C. Patra [Inde] ; Sang-Soo Lee [Corée du Sud] ; Chiranjib Chakraborty [Corée du Sud] | Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. |
000229 (2020) |
Asmaa Altamimi [Arabie saoudite] ; Raghib Abu-Saris [Arabie saoudite] ; Ashraf El-Metwally [Arabie saoudite] ; Taghreed Alaifan [Arabie saoudite] ; Aref Alamri [Arabie saoudite] | Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory |
000232 (2020) |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
000233 (2020) |
Youngchang Kim [États-Unis] ; Robert Jedrzejczak [États-Unis] ; Natalia I. Maltseva [États-Unis] ; Mateusz Wilamowski [États-Unis] ; Michael Endres [États-Unis] ; Adam Godzik [États-Unis] ; Karolina Michalska [États-Unis] ; Andrzej Joachimiak [États-Unis] | Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. |
000236 (2020) |
Sunny H. Wong [Hong Kong] ; Rashid Ns Lui [Hong Kong] ; Joseph Jy Sung [Hong Kong] | Covid-19 and the Digestive System. |
000239 (2020) |
Tiffany Tang [États-Unis] ; Miya Bidon [États-Unis] ; Javier A. Jaimes [États-Unis] ; Gary R. Whittaker [États-Unis] ; Susan Daniel [États-Unis] | Coronavirus membrane fusion mechanism offers as a potential target for antiviral development. |
000244 (2020) |
Le Chang [République populaire de Chine] ; Ying Yan [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
000246 (2020) |
Pradip Dashraath [Singapour] ; Wong Jing Lin Jeslyn [Singapour] ; Lim Mei Xian Karen [Singapour] ; Lim Li Min [Singapour] ; Li Sarah [Singapour] ; Arijit Biswas [Singapour] ; Mahesh Arjandas Choolani [Singapour] ; Citra Mattar [Singapour] ; Su Lin Lin [Singapour] | Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. |
000247 (2020) |
Barbara Holstein | Coronavirus 101 |
000249 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
000251 (2020) |
Xi Zhang [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Lei Wen [République populaire de Chine] ; Huiping Shuai [République populaire de Chine] ; Dong Yang [République populaire de Chine] ; Yixin Wang [République populaire de Chine] ; Yuxin Hou [République populaire de Chine] ; Zheng Zhu [République populaire de Chine] ; Shuofeng Yuan [République populaire de Chine] ; Feifei Yin [République populaire de Chine] ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] | Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation. |